Moxatag approval a crucial first for MiddleBrook
MiddleBrook Pharmaceuticals secured a crucial endorsement for its Pulsys oral drug delivery system last week when the US Food and Drug Administration (FDA) approved the company's lead pipeline product, Moxatag, as a once-daily treatment for...